PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Aug-2021 Otsuka Awarded Grant for Phase 2 Trial Combining Novel Anti-Tuberculosis Compound OPC-167832 with Delamanid and Bedaquiline Businesswire
09-Aug-2021 Amplity's Chief People Officer Named Delaware Valley Human Resources Person of the Year Newswire
09-Aug-2021 American Medical Association Issues New Category III CPT Code for ZOLL Medical’s TherOx SSO2 Therapy Businesswire
09-Aug-2021 Impossible Foods Appoints New Chief People Officer and Chief Financial Officer Ahead of Category Expansion Businesswire
09-Aug-2021 DNAnexus Platform Exceeds Online Security Standards in President Biden’s Executive Order Aimed at Protecting American Infrastructure from Cyberattacks Businesswire
09-Aug-2021 Dalrada Health and Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture Businesswire
09-Aug-2021  What Retail and Brand Executives Need to Know about Customer Data for the 2021 Holiday Season Businesswire
09-Aug-2021 Imvax Further Strengthens Leadership Team with Appointment of Josh Muntner as Chief Financial Officer Businesswire
09-Aug-2021 Dovetail Genomics and Revive & Restore Form Partnership to Sequence and Assemble Genomes of 15 Endangered Species Businesswire
09-Aug-2021 Biomarkers Markets, 2026 by Type (Safety, Efficacy, Validation), Disease (Cancer, Neurological), Application (Diagnostics, Drug Discovery & Development, Personalized Medicine) - ResearchAndMarkets.com Businesswire
09-Aug-2021 Epizyme Announces CEO Succession Businesswire
09-Aug-2021 Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update Businesswire
09-Aug-2021 Premier Inc. Brands Technology and Services Platform “PINC AI™” Businesswire
09-Aug-2021 Gastric Cancer Drugs Global Market Report 2021 Featuring Eli Lilly and Co, Novartis, Merck KGaA, Otsuka Pharmaceutical, and F. Hoffmann-La Roche - ResearchAndMarkets.com Businesswire
09-Aug-2021 Virios Therapeutics Featured in Bloomberg TV Interview Businesswire
09-Aug-2021 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
09-Aug-2021 Dicerna Announces Second Quarter 2021 Financial Results and Provides a Business Update Businesswire
09-Aug-2021 Cybin to Present at Canaccord Genuity’s 41st Annual Growth Conference on August 10th Businesswire
09-Aug-2021 Sesen Bio Reports Second Quarter 2021 Financial Results and Significant Global Progress for Vicineum™ Businesswire
09-Aug-2021 Eagle Pharmaceuticals Reports Second Quarter 2021 Results Businesswire